Mon, Oct 20, 2014, 11:01 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Stereotaxis Inc. Message Board

  • kiksbutt kiksbutt Aug 8, 2013 7:09 AM Flag

    Wow what a horirble ER! This is going back to $2

    Revenue for the first six months of 2013 was $18.1 million, down 20.4% compared to $22.8 million in the first six months of 2012.

    Gross margins down again YoY. Cancelled orders, interest expense up, revenues down YoY, Cash burn up since they can't sell anything, capital rasiing at $3!! LOL

    The net loss was $(7.9) million for the first six months of 2013 versus $(3.0) million for the comparable period in 2012.

    And perhaps the biggest dagger, At June 30, 2013, Stereotaxis had cash and cash equivalents of $4.1 million, compared to $9.6 million at March 31, 2013.

    Wow!!!! how do you burn through so much cash?!?! Secondary anyone??? LMFAO

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I hope my negative comments over the last week helped someone sell in $9-$10 range and save you money.

    • Desperate days for STXS. The 400% share price pop was nice while it lasted (1 week!), but a grim reality looms. Burdened with high cash flows, overloaded with managers, "insiders", and their hangers-on, shrinking sales ... Not a pretty picture. Can they parlay the recent FDA product approval into dollars, in time to keep the jackals at bay? Or will they do a slow fade to obscurity, like a thousand other biotechs before them? My guess: they can't do it in time, and they fade.
      Tune in next quarter; bring popcorn.

      Sentiment: Strong Sell

 
STXS
1.93+0.05(+2.66%)Oct 20 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.